APA (7th ed.) Citation

Goldschmidt, H., Sonneveld, P., Cremer, F. W., Holt, B. v. d., Westveer, P., Breitkreutz, I., . . . Lokhorst, H. M. (2003). Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Annals of hematology, 82(10), . https://doi.org/10.1007/s00277-003-0685-2

Chicago Style (17th ed.) Citation

Goldschmidt, Hartmut, et al. "Joint HOVON-50/GMMG-HD3 Randomized Trial on the Effect of Thalidomide as Part of a High-dose Therapy Regimen and as Maintenance Treatment for Newly Diagnosed Myeloma Patients." Annals of Hematology 82, no. 10 (2003). https://doi.org/10.1007/s00277-003-0685-2.

MLA (9th ed.) Citation

Goldschmidt, Hartmut, et al. "Joint HOVON-50/GMMG-HD3 Randomized Trial on the Effect of Thalidomide as Part of a High-dose Therapy Regimen and as Maintenance Treatment for Newly Diagnosed Myeloma Patients." Annals of Hematology, vol. 82, no. 10, 2003, https://doi.org/10.1007/s00277-003-0685-2.